Colby Pacheco, Psychiatric Nurse Practitioner
4013 Northwest Expressway, Suite 105, Oklahoma City
4.4(29 Google reviews)
United States
5 listed treatment centers serving Oklahoma City and the surrounding area.
4013 Northwest Expressway, Suite 105, Oklahoma City
4.4(29 Google reviews)
4113 Northwest Expressway, Suite 105, Oklahoma City
2.0(1 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Oklahoma City.
6.4 miles away · Midwest City
10.9 miles away · Moore
10.9 miles away · Moore
13.1 miles away · Edmond
13.1 miles away · Edmond
13.1 miles away · Edmond
For people in Oklahoma City considering SPRAVATO®, the financial picture involves more than the medication itself. Both the medication and the supervised treatment visit, including required monitoring, may be billed. Ask for an estimate that separates these charges and explains your possible deductible, copay, or coinsurance responsibilities.
Coverage varies by plan. Prior authorization is common, and your insurer may request records of earlier antidepressant trials. Ask your prescribing clinician what documentation is needed, such as which medications you tried and how you responded. A treatment recommendation does not guarantee insurance approval.
Medicare coverage may fall under Part B or Part D, depending on the plan and treatment setting. Oklahoma Medicaid coverage also depends on the plan and setting. Confirm benefits directly with your insurer and the treatment center; a directory listing does not establish that a center accepts your coverage.
Manufacturer savings programs exist for eligible commercially insured patients, but eligibility restrictions apply, and these savings programs are not for people using government insurance. Ask about current terms rather than assuming you qualify.
Before starting, ask the center and insurer:
Get coverage and estimated patient responsibility clarified before scheduling a recurring course of visits.
SPRAVATO® visits take place only in a healthcare setting certified through the SPRAVATO® REMS program. You administer the nasal spray yourself under direct observation from a healthcare provider; it is never a take-home treatment.
This directory currently has no listed center in Oklahoma City. The supplied listing summary includes Del City as a nearby search option, but its REMS certification is not confirmed in these records. Contact prospective locations to verify current certification, whether they are accepting patients, and their scheduling process. No other Oklahoma cities are provided here as alternatives. You can also ask your prescribing clinician for help finding a certified setting.
For treatment-resistant depression, the usual labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule appropriate for you; do not assume everyone follows the same long-term pattern.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and assessment before leaving. The total appointment may be longer than two hours. When arranging time off work or caregiving coverage, allow for the full visit and transportation rather than just the spray administration.
Arrange for someone else to drive you home after every appointment. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and discharge requirements before relying on a hired ride. A backup driver can help prevent transportation problems from disrupting scheduled care.
This directory currently has no listed SPRAVATO® center in Oklahoma City. Del City appears in the supplied listing summary, but REMS certification is not confirmed in these records. Before scheduling, ask the location to verify current certification and availability. Your prescribing clinician can also help you look for a certified treatment setting.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your treatment history and health risks to determine whether it is appropriate.
Coverage depends on your plan and the treatment setting. The medication and observed monitoring visit may both be billed, so ask about each separately. Prior authorization and records of previous antidepressant trials are common requirements. Medicare and Oklahoma Medicaid may cover treatment depending on the plan and setting, but neither coverage nor a center’s participation should be assumed.
You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours afterward, including for sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for other parts of the appointment. Someone else must take you home, and you cannot drive until the next day after a restful sleep.
Spravato can cause sedation, dissociation, respiratory depression, and increased blood pressure. Dissociation can involve feeling disconnected from yourself or your surroundings. Its boxed warnings also address abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medications, and substance use history openly with your clinician before starting.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behaviors, and it does not replace hospitalization when clinically needed. Do not wait for a treatment consultation during a crisis. Call or text 988 for immediate crisis support, or call 911 in an emergency, including when there is immediate danger.
Approved uses, nearby treatment centers, and medically sourced patient guides.